Skip to content
Clinical Trials – home

EVAGGELISMOS"General Hospital of Athens

Verifiedinfo

Greece Ipsiladou 45-47, 106 76 Athens, Greece

  • 20 trials recruiting
  • Plasma cell myeloma · Colitis ulcerative · Crohn's disease
  • Adults and children

About Specializations

EVAGGELISMOS"General Hospital of Athens in Athens, Greece specialises in clinical trials of conditions such as Plasma cell myeloma, Colitis ulcerative, Crohn's disease, Plasma cell myeloma refractory, and other specialisations. This site conducts important research.

Main research areas of the site

Hematologic Oncology

The medical center is at the forefront of hematologic oncology, focusing on innovative treatments for blood cancers. The ongoing research is dedicated to improving outcomes for patients with challenging conditions such as Acute Myeloid Leukemia (AML).

  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Relapsed/Refractory Blood Cancers

Through cutting-edge clinical trials, the center is exploring new therapeutic agents like AB8939, aiming to enhance the safety and efficacy of treatments for patients with relapsed or refractory AML. This research is pivotal in establishing new standards of care and expanding treatment options for hematologic malignancies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ipsiladou 45-47106 76 AthensGreece
Recruiting now
20 trials
Conditions studied
32
Partner status
Verified

More sites in AthensGreece

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

51 clinical trials

Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Novartis Pharma AG
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hellenic Society Of Hematology
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Celgene Corp.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Janssen Cilag International
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Celgene Corp.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.